Effects of physiological concentrations of steroid hormones and interleukin-11 on basal and stimulated production of interleukin-8 by human osteoblast-like cells with different functional profiles

Clinical and Experimental Rheumatology

Volumn 22, Issue 1, 2004, Pages 79-84

  Dovio, Andrea ^a   Sartori, Maria Luisa ^a   Masera, Rosa Gabriella ^a   Perotti, Laura ^b   Perotti, Livio ^b   Angeli, Alberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

Cortisol; Estradiol; IL 11; IL 8; Osteoblast; Rheumatoid arthritis

Indexed keywords

ESTRADIOL; GLUCOCORTICOID; HYDROCORTISONE; INTERLEUKIN 11; INTERLEUKIN 1BETA; INTERLEUKIN 8; STEROID HORMONE;

ARTICLE; CELL FUNCTION; CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTATION; HORMONE INHIBITION; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SUPERNATANT; SUPPLEMENTATION;

CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; HUMANS; HYDROCORTISONE; INTERLEUKIN-1; INTERLEUKIN-11; INTERLEUKIN-8; OSTEOBLASTS; RECOMBINANT PROTEINS;

EID: 1242286471     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. WUYTS A, PROOST P, VAN DAMME J: Interleukin-8 and other CXC chemokines. In THOMPSON A (Ed.): The Cytokine Handbook, London, Academic Press 1998: 271-311.
2. BILBE G, ROBERTS E, BIRCH M, EVANS DB: PCR phenotyping of cytokines, growth factors and their receptors and bone matrix proteins in human osteoblast-like cell lines. Bone 1996; 19: 437-45.
3. LISIGNOLI G, TONEGUZZI S, GRASSI F et al.: Different chemokines are expressed in human arthritic bone biopsies: IFN-γ and IL-6 differently modulate IL-8, MCP-1 and RANTES production by arthritic osteoblasts. Cytokine 2002; 20: 231-8.
4. LISIGNOLI G, TONEGUZZI S, POZZI C et al.: Pro-inflammatory cytokines and chemokine production and expression by human osteoblasts isolated from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1999; 26: 791-9.
5. SUNYER T, LEWIS J, COLLIN-OSDOBY P, OSDOBY P: Estrogen's bone protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells. J Clin Invest 1999; 103: 1409-18.
6. COLLIN-OSDOBY P, KIRSCH D, ANDERSON F, JOOST O, DEAN A, OSDOBY P: The chemokine IL-8 as an autocrine inhibitor of osteoclast bone resorptive activity via IL-8 receptors expressed by avian osteoclasts and human osteoclast-like cells. J Bone Miner Res 1996; 11: S357 (abstr.).
7. FULLER K, OWENS J, CHAMBERS T: Macrophage inflammatory protein-1 and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts. J Immunol 1995; 154: 6065-72.
8. ENDO H, AKAHOSHI T, TAKAGISHI K, KASHIWAZAKI S, MATSUSHIMA K: Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. Lymphokine Cytokine Res 1991; 10: 245-52.
9. KANEKO S, SATOH T, CHIBA J, JU C, INOUE K, KAGAWA J: Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther 2000; 6: 71-9.
10. FURUZAWA-CARBALLEDA J, ALCOCER-VARELA J: Interleukin-8, interleukin-10, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression levels are higher in synovial tissue from patients with rheumatoid arthritis than in osteoarthritis. Scand J Immunol 1999; 50: 215-22.
11. ROTHE L, COLLIN-OSDOBY P, CHEN Y et al.: Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8. Endocrinology 1998; 139: 4353-63.
12. EDWARDS SW, HALLETT MB: Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol Today 1997; 18: 320-4.
13. CHAUDHARY LR, AVIOLI LV: Regulation of interleukin-8 gene expression by interleukin-1beta, osteotropic hormones, and protein kinase inhibitors in normal human bone marrow stromal cells. J Biol Chem 1996; 271: 16591-6.
14. CHAUDHARY LR, AVIOLI LV: Dexamethasone regulates IL-1 beta and TNF-alpha-induced interleukin-8 production in human bone marrow stromal and osteoblast-like cells. Calcif Tissue Int 1994; 55: 16-20.
15. CHAUDHARY LR, SPELSBERG TC, RIGGS BL: Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: lack of regulation by 17 beta-estradiol. Endocrinology 1992; 130: 2528-34.
16. TREPICCHIO WL, DORNER AJ: Interleukin-11: a gp130 cytokine. Ann NY Acad Sci 1998; 856: 12-21.
17. TREPICCHIO WL, WANG L, BOZZA M, DORNER AJ: IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB. J Immunol 1997; 159: 5661-70.
18. TREPICCHIO WL, BOZZA M, PEDNEAULT G, DORNER AJ: Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol 1996; 157: 3627-34.
19. McKAY LI, CIDLOWSKI JA: Molecular control of immune/inflammatory responses: interactions between nuclear factor-kB and steroid receptor-signaling pathways. Endocr Rev 1999; 20: 435-59.
20. MORELAND L, GUGLIOTTI R, KING K et al.: Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis. Arthritis Res 2001; 3: 247-52.
21. SIDDIQI A, BURRIN JM, WOOD DF, MONSON JP: Tri-iodothyronine regulates the production of interleukin-6 and interleukin-8 in human bone marrow stromal and osteoblast-like cells. J Endocrinol 1998; 157: 453-61.
22. DOVIO A, SARTORI ML, MASERA RG, RACCA S, ANGELI A: Inhibitory effect of physiological concentrations of cortisol but not estradiol on interleukin (IL)-6 production by human osteoblast-like cell lines with different constitutive IL-6 expression. Cytokine 2001; 15: 47-52.
23. BLAND R: Steroid hormone receptor expression and action in bone. Clin Science 2000; 98: 217-40.
24. RAO LG, SUTHERLAND MK, REDDY GS, SIUCALDERA ML, USKOKOVIC MR, MURRAY TM: Effects of 1alpha,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-beta estradiol. Bone 1996; 19: 621-7.
25. LAJEUNESSE D: Effect of 17 beta-estradiol on the human osteosarcoma cell line MG-63. Bone Miner 1994; 24: 1-16.
26. LU ZY, ZHANG XG, GU ZJ et al.: A highly sensitive quantitative bioassay for human interleukin-11. J Immunol Methods 1994; 173: 19-26.
27. ELIAS JA, TANG W, HOROWITZ MC: Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. Endocrinology 1995; 136: 489-98.
28. BELLIDO T, STAHL N, FARRUGGELLA TJ, BORBA V, YANCOPOULOS GD, MANOLAGAS SC: Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J Clin Invest 1996; 97: 431-7.
29. CHEREL M, SOREL M, LEBEAU B et al.: Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11. Blood 1995; 86: 2534-40.
30. KANEKO M, TOMITA T, NAKASE T et al.: Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis. Rheumatology (Oxford) 2001; 40: 247-55.
31. WLUKA AE, CICUTTINI FM, SPECTOR TD: Menopause, oestrogens and arthritis. Maturitas 2000; 35: 183-99.
32. CROFFORD LJ: The hypothalamic-pituitary-adrenal axis in the pathogenesis of rheumatic diseases. Endocrinol Metab Clin North Am 2002; 31: 1-13.
33. STRAUB RH, GUNZLER C, MILLER LE, CUTOLO M, SCHOLMERICH J, SCHILL S: Anti-inflammatory cooperativity of corticosteroids and norepinephrine in rheumatoid arthritis synovial tissue in vivo and in vitro. FASEB J 2002; 16: 993-1000.
34. PEROTTI LA, PERETTI L, LOVINO C, MASERA RG, SARTORI ML, ANGELI A: Concentration of cortisol in the synovial fluid of patients with untreated rheumatoid arthritis. Relation to in vitro IL-8 production by synovial mononuclear cells. Ann N Y Acad Sci 1999; 876: 255-8.
35. MORELAND LW, O'DELL JR: Glucocorticoids and rheumatoid arthritis: back to the future? Arthritis Rheum 2002; 46: 2553-63.
36. GEORGANAS C, LIU H, PERLMAN H, HOFFMANN A, THIMMAPAYA B, POPE RM: Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun. J Immunol 2000; 165: 7199-206.
37. DOVIO A, SARTORI ML, MASERA RG et al.: Autocrine down-regulation of glucocorticoid receptors by interleukin-11 in human osteoblast-like cell lines. J Endocrinol 2003; 177: 109-17.
38. LIU F, AUBIN JE, MALAVAL L: Expression of leukemia inhibitory factor (LIF)/interleukin-6 family cytokines and receptors during in vitro osteogenesis: differential regulation by dexamethasone and LIF. Bone 2002; 31: 212-9.
39. LIN SC, O'BRIEN CA, MANOLAGAS SC: Sex steroids decrease and glucocorticoids increase the levels of gp130 protein in bone marrow-derived stromal cells: correlation with altered IL-6 induced DNA-binding activity of STAT1 and STAT3 complexes. J Bone Miner Res 1996; 11: S161 (abstr.).